Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes

BACKGROUND AND AIMS: We explored the potential for differential efficacy of vedolizumab between early and late ulcerative colitis [UC] with evaluation of clinical, endoscopic, and histological endpoints. METHODS: This was a multicentre, multinational, open-label study in patients with moderately-to-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JOURNAL OF CROHNS & COLITIS 2024-04, Vol.18 (4), p.540-547
Hauptverfasser: Vermeire, Severine, Hanzel, Jurij, Lowenberg, Mark, Ferrante, Marc, Bossuyt, Peter, Hoentjen, Frank, Franchimont, Denis, Palatka, Karoly, Peeters, Harald, Mookhoek, Aart, de Hertogh, Gert, Molnar, Tamas, van Moerkercke, Wouter, Lobaton, Triana, Clasquin, Esme, Hulshoff, Melanie S, Baert, Filip, D'Haens, Geert
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!